Member Info for Fastfood

That is an excellent Explanation. Expert. Thank you.

Cheers for that Owl. Although 2m a day is plenty enough.

Can they next 18 month get the Share Count down to 5.9b ? That would carry significant return of Value to Shareholders.

Booom Bermondsey lol… 😂

Ouuu is something occurring ?? Up she goes..

Recent mini buying spree nudging us up.

Also ; it would be unusual to achieve CLIA before AGM as they still need to vote at AGM for the Options to carry.

Hogbog the saviour of Rome.

“The DEX-G2 gastric cancer test does not hold a standalone CLIA accreditation, as it is a laboratory-developed test (LDT) rather than an FDA-approved kit. However, the blood test is processed through partner facilities in the US that are explicitly CLIA-certified and CAP-accredited”.

That explains that one.

There’s also some things on Cizzle Bio website I am not happy with.

The Gastric Test clearly states 1000 patients tested and 95% accuracy.

Whilst we have no information or feedback. It says 95% accuracy but what about the Trials ? No info.

I may be off the mark here but is the Gastric Test ahead of us ? What about CLIA for that one ?

Do we need CLIA to make Clinical Trials official re results ??

Again - All a bit (A lot clunky) from Cizzle re no ability to Q and A.

We only have the May Options RNS to hang on to. Was that a red herring ??

They aren’t exactly shouting anything from rooftops are they ?

ASCO 160 Countries. Ciz Bio did not conduct any presentation. Only last year about potentially saving Medicare $518m through early diagnosis.

Clunky.

Upon checking it was 400k purchases back in April not 4m. So I have it wrong.

It just threw me a bit because they recently went in and bought 4m but then reduced to 2m at a 10p lower price. So in general they have increased purchases as price lowered.

Regard the recent 2m Shares at 10p lower than the 4m Shares (You would want that other way round) I guess they are protecting the buying pot and no crystal ball re future Market behaviour.

I stand corrected.

Onwards we go.

On reflection I believe I could be wrong.

When latest BB started April they were purchasing 400k Shares at 4.90. Recently it’s 4m and 2m at these lower levels which is what we want and hasten to add the reason for extension from £250m to £350m first tranche.

It just threw me a bit because they did a 4m Share purchase but then went down to £2m on a 10p lower price. Which you would want the other way round. No crystal ball method available I expect.

Onwards we go.

Currently buying and cancelling 2m Shares per day at 430/440p. Go back to when £750m buyback program started it was 4m Shares at 480p. Now I am no expert here but you’d think Citi would know what they are doing. Seems not because if they had spent less at the beginning then they would have been able to increase their Share buyback as is now at lower prices. Instead it’s the other way round. They are cancelling less Shares at lower prices !!

Any thoughts or experience on the matter ?

Whilst we cannot predict future SP / It seems logical to me that the aim is to cancel as many Shares as possible within the £350m first tranche. But this I clearly not being achieved.

Really surprised there is no communication or feedback from Cizzle on this matter. All Top Secret then. Good thing or Bad thing ? You’d think if CLIA expected Q2 that they would aim for mid June as latest as why declare Q2 knowing it could go to last day ? You wouldn’t unless you were pathological.

“Yes, the American Society of Clinical Oncology (ASCO) annual meeting is widely regarded as the biggest clinical cancer research conference in the world.The massive annual event typically attracts over 40,000 oncology professionals, scientists, and patient advocates from over 160 countries, and features thousands of groundbreaking studies and abstracts.If you are looking to understand the scale or scope of the event, I can:Provide details on the major medical breakthroughs and clinical trials presented at recent meetings….”

2032 £6-£8.

Also it angers me that Cizzle never make the News. Everyone else seems to. Conspiracy is that maybe they purposely keeping it out of the News !!! Despite now high media profile re focus on Cancer !!

I’m beginning to think that Accreditation could stretch out beyond June but not after first 2 weeks in July. Nothing but a hunch but wouldn’t put it passed them to miss Timeline / Tank the SP / and then announcement.

Nobody has asked the Qeuestion yet as to whether the Ciz1b biomarker is effective re other Cancers apart from Lung.

I fancy it is.

What we do know is that they release no public News re the scope of this Test and its wider potential.

I’m sure they will all in good time. Or they could just be trying to string us all along ? Inc our Investor FL and he has ploughed millions in. I am sure the will have assessed all the competition and timelines. Or maybe not ?

Svend. Serious Question.

Do you think Tesco sp can reach £8 by 2032 ?

Excellent News Vincent on the all clear and your friend. Let’s hope that the Ciz test EFFECTIVELY supports scan selection and also Post scan / operation follow up.

I recently saw a Lung Cancer screening Truck in my local Tesco car park for 5-7 days.

I wondered if they were using our blood test in some way ?

Either way our blood test should help filter out or in those who need the scan. Much more efficient you’d think and support good outcomes for patients and the UK National screening program for Lung Cancer.

It’s coming.